PHARMACEUTICALS: Trump Tariff Plans

By A.I. and Staff Reporters

SPONSOR: http://www.CertifiedMedicalPlanner.org

***

***

Trump says pharma tariffs could be as high as 250%

The president revealed that he plans to formally announce tariffs on the pharmaceutical industry “within the next week or so” in an attempt to force drug manufacturing to the US, he told CNBC several days ago.

PBMs: https://medicalexecutivepost.com/2019/01/18/on-pbms-pharmacy-benefits-management/

It would start with a “small” tariff, Trump said, before rising to 150% in a year to a year and a half, and eventually to 250%.

Pharma companies have argued that tariffs could drive up costs and threaten their ability to fund research for new medicines.

COMMENTS APPRECIATED

Like and Subscribe

***

***

PODCASTS: FDA Pharmaceutical Industry Ties

CONFLICTS OF INTEREST?

The New York Times Had an Excellent Article on the FDA on September 2, 2021.

The Article Described How the FDA Began Receiving Funding from the Pharmaceutical Industry Itself to Pay for FDA Employee Salaries in 1992–a Potential Conflict-of-Interest. Subsequently, a Study Found that 1/3 of Drugs Approved by the FDA Were Found to Have Safety Problems from 2000 -2010. Another Potential Conflict-of-Interest is Number of FDA Regulators Who Leave Their Positions to Take High-Paying Jobs at Pharmaceutical Companies.

By Eric Bricker MD

FDA rescinds emergency authorization for COVID-19 antibody treatment  bamlanivimab | TheHill

PODCAST:

***

YOUR COMMENTS ARE APPRECIATED.

Thank You

****

***